No Data
No Data
Carna Biosciences: Notice regarding revisions to earnings forecasts
Softness, weighed down by falling US stocks and rising US long-term interest rates.
[Emerging Markets Individual Stock Global Strategy] Today's emerging markets are expected to experience a sluggish trend. Yesterday, on the 9th, the Dow Jones Industrial Average fell by 240.59 points (-0.54%) to 44,401.93, marking three consecutive days of decline. There was some buying driven by hopes for additional rate cuts from the Federal Reserve and China's economic support plans, but this was outweighed by selling due to geopolitical risks resulting from the collapse of Assad's regime in Syria, leading to a decline. The Nasdaq also faced profit-taking selling, along with semiconductors like nvidia (
Carna Biosciences Sees FY Loss Y2.23B
Carna Biosciences: Financial results presentation materials for the 3rd quarter of the fiscal year ending 2024/12
Carna Biosciences: Summary of Financial Results for the 3rd Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)
Morinaga Milk, mcdonald's, Toyo Suisan, Eisai (8th) (1429-5463)
※Please note that the above calendar is tentative and subject to change based on the company's convenience. --------------------------------------- November 8th (Fri) <1429> Japan Aqua <1435> RoboHome <143A> Ishin <1450> Tanaka Construction Industry <1451> KHC <1518> Mitsui Matsushima HD <151A> Dai <167A> Ryo
No Data